transferase is partly linked with the reproductive cycle of the animal. At times close to spawning, the latency diminished. At this time the mono-oxygenase activity in the same membrane structure is very low (Koivusaari et al., 1980), i.e. there is a difference in the membrane structure and less surface-oriented protein having a functional relationship with UDP-glucuronosyltransferase. This may contribute to the lessened latency. The increase of UDPglucuronosyltransferase activity at spawning time of rainbow trout cannot, however, be explained by the changes in latency.
Sulphation and glucuronidation are major pathways of drug metabolism that share many substrates; almost invariably both conjugates are found when, for instance, a phenolic substrate is administered in vivo (Dutton, 1980; . Thus, the transferases involved compete for the same substrates. Several sulphotransferases and UDPglucuronosyltransferases have been purified, mainly from the liver, and have been biochemically characterized towards a number of substrates (Burchell, 1981 ; Roy, 1981 ; Jakoby et a [., 1983) . Thus, in recent years, much insight has been gained into the enzyme kinetics and regulatory properties of the (semi-)purified transferases. However, much less is known about the importance of these properties of the purified enzymes to the overall activity of the reactions catalysed by them in intact organisms or cells. In these systems other factors may determine the properties of the overall reaction, such as the rate at which the substrate becomes available for conjugation, the availability of the cofactors for conjugation, and competition of sulphation and glucuronidation for the same substrate inside a cell. Moreover, whereas for most substrates the liver certainly is the main site of their conjugation, other organs will contribute to various extents to the total conjugation in vioo. Below we will show how K , and V,,,, values of the transferases do play a role, but how the interpretation of experiments in vivo involving conjugation is complicated by other processes governing the overall activity of conjugation. This will be illustrated with the substrate harmol, which is sulphated and glucuronidated both inside and outside the liver.
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Dose-dependence of the ratio between sulphation and glucuronidation
When sulphation and glucuronidation of phenol? is studied in vivo, usually at increasing dose of the substrate, the percentage of the dose that is sulphated decreases, whereas that which is glucuronidated increases (Mulder, 1981) . Fig. l(c) illustrates this for harmol. Several explanations can account for this phenomenon, namely, a depletion of inorganic sulphate at high dose of the substrate, differences in affinity for sulphation and glucuronidation, and a non-homogeneous distribution of the transferases in the liver.
I. Sulphate depletion. Since sulphation requires a continuous supply of inorganic sulphate to form the co-substrate of su 1 p hat ion, 3'-phosphoadenosine 5'-phosp hosul p hate (PAPS), sulphate might become depleted at a high dose of a substrate, resulting in decreased sulphation. In support of this it was found that administration of inorganic sulphate or a precursor like cysteine, could enhance sulphation at doses of paracetamol and harmol that indeed diminished sulphate availability (Galinsky & Levy, 1981 ; Krijgsheld er al., 1981 Krijgsheld er al., , 1982a Lin & Levy, 1981) . This is in agreement with an apparent K , of inorganic sulphate in plasma for overall sulphation of 0 . 3 m~ in the rat (Krijgsheld et al., 39826) . Thus when the plasma sulphate level in the dat is decreased from I.OmM (normal) to 0.2mM, the raje of sulphation (' VmaX,') will unavoidably decrease because PAPS is no longer saturating for the sulphotransferake.
However, conditions can be chosen such that sulphate availability in vivo is not rate-limiting, and yet sulphation still decreases at higher dose, in spite of an ample supply of inorganic sulphate, as with phenol (Mulder & Meerman, 1978) and harmol (Koster et al., 1982a) . Therefore, although sulphate depletion will be one cause of the decrease of sulphation at increasing dose, it certainly will not b t the only cause.
VOl. 12 2. Differences in afinity of sulphation and glucuronidation. An alternative possibly is that sulphation and glucuronidation have (very) different K , values for the same substrate. Side-by-side comparison of K , and V,,,. values for a number of substrates for both glucuronidation and sulphation has been performed with purified enzymes ; the available data seem to suggest that the K , values for sulphation are (much) lower than those for glucuronidation (see e.g. Mulder & Meerman, 1978) . If isolated perfused organs or isolated cells are used (in which a constant, high level of inorganic sulphate can be provided), one can determine whether such differences in affinity for the overall conjugation reaction (including co-substrate synthesis and group transfer) exist. For a number of phenols, indeed, such differences have been established. Thus harmol is preferentially sulphated at low substrate concentration, whereas at increasing concentration, glucuronidation takes over (Figs. la and 16); in fact, it 'compensates' for the 'loss' of sulphation due to its saturation (Pang et al., 1981) . Similar findings have been reported with other substrates (see Mulder, 1981 , for review). Therefore a lower K , for the overall sulphation process than for glucuronidation may be the reason why, for some substrates, glucuronidation increases more than sulphation at higher doses.
3. Non-homogeneous distribution of sulphation and glucuronidation in the liver. For many enzyme activities a nonhomogeneous distribution has been determined in the liver (Jungermann & Katz, 1982) . There is strong evidence suggesting that sulphation is mainly located in zone 1 (periportal) cells, whereas glucuronidation may be more concentrated in zone 3 (centrilobular) cells (Pang & Terrell, 1981 ; Conway et al., 1982; Pang et al., 1983) . This also might present an explanation for the predominance of sulphation at low dose: the zone-1 cells will be first exposed to the substrate entering the liver, and will convert it mainly to the sulphate conjugate. Only when uptake by the zone-I cells becomes 'saturated' can the substrate reach zone 3, resulting in glucuronidation. The results from perfusion of the fiver with harmol in the retrograde direction lend credence to such an explanation (Panget al., 1983). However, since the shift in ratio between sulphation and glucuronidation is also observed in incubations of harmol ( Fig. la) and other substrates with isolated hepatocytes (in which zonal differences along the path of flow of the blood are lost), a non-homogeneous distribution of the enzymes is most likely not the reason for this shift.
Competition between sulphation and glucuronidation.
At increasing dose or concentration of a substrate, the rate of sulphation follows more or less Michaelis-Menten kinetics, whereas the rate of glucuronidation shows a deviant behaviour in all intact cell systems: a 'lag-phase' at low substrate concentration (Fig. 1) . This has also been observed for other substrates (Conway et al., 1982 ; see also Koster & Mulder, 1982) . Most especially the fact that this occurs also in isolated hepatocytes in which all cells are equally exposed to the substrate makes it very likely that such a feature is due to competition of the transferases for the same substrate under conditions in which the substrate supply to the intracellular transferases is rate-limiting ( Koster & Mulder, 1982) ; if the rate of metabolism is very high as compared with the rate of substrate supply, a nonlinear relationship will exist between the extracellular and the intracellular substrate Concentration. When the conjugation reaction with the lower K , becomes saturated, the intracellular concentration then increases more than linearly with the extracellular concentration, so that the rate of the alternative reaction, glucuronidation, also suddenly increases by an amount that is more than proportional to the extracellular substrate concentration. In agreement with this, the aberrancy in glucuronidation kinetics appears when sulphation of harmol is selectively inhibited by 2,6-diehloro-4-nitrophenol (Koster et al., 1982a) , indicating that it was due to the competition between the two conjugations.
Extrahepatic conjugation in the rat in vivo
Although the liver very actively metabolizes many phenols, extrahepatic conjugation also plays a role in uivo. Thus the clearance of harmol under steady-state infusion conditions is approx. 50ml/min in a 300g rat, which is more than double the blood flow through the liver (20-25 ml/min). Extrahepatic conjugation must account for at least 50% of the metabolism of harmol. Indeed, it had been shown that the kidneys, lungs and intestines can conjugate various phenols with sulphate and glucuronate (Gram, 1980) . Recently Machida et al. (1982) compared the fate of 4-nitrophenol administered either in the jugular or in the portal vein; they reported that some 50% of the conjugation took place outside the liver.
We have performed similar in viuo experiments with harmol, but have used steady-state infusions (1 67 nmol/ min), either in the jugular vein or in the portal vein (Fig. 2) . The final glucuronidation rate is 39nrnol/min during the jugular infusion, and 60nmol/min during the portal infusion; for sulphation these rates are 116 and 101 nmol/min respectively. Furthermore, there is a pronounced difference in the concentration of unconjugated harmol reached in arterial blood under steady-state conditions : 1 . 1 7~~ (portal infusion) versus 2 . 8 5~~ (jugular infusion). This indicates that the liver takes up a considerable percentage (approx. 60% of the harmol infused into the portal vein) which thus never reaches the general circulation.
Conjugation of harmol in the lung seems of minor importance, since during perfusion of the isolated rat lung with 5 0 p~ harmol, very little sulphation (2nmol/min at a perfusion rate of 30ml/min) and negligible glucuronidation was found (J. R. Dawson et al., unpublished work). The kidneys which receive a blood flow of approx. 30ml/min, might be the organs mainly responsible for the high percentage of extra-hepatic sulphation. Indeed, for several substrates appreciable sulphation has been found in the isolated perfused kidney (Elbers et al., 1980; Emslie et al., 1981) .
Inhibition of sulphation by 2,6-dichloro-4-nitrophenol (DCNP) and pentachlorophenol (PCP)
Selective inhibition of glucuronidation and sulphation would facilitate studies on the factors that are decisive in the pharmacokinetics of conjugation in uiuo. Unfortunately, no Harmol was infused at a rate of 0.76pmol/min after an intravenous loading dose of 4.8pmol. Bile and urine were collected as indicated by the mid-point of each collection period, and in each fraction harmol glucuronide and harmol sulphate were determined. After 2 h an intravenous injection of DCNP (26pmol/kg) was given. M e a n s k s .~. are given for five rats; the body weight of the rats was about 300g each. selective inhibitors of glucuronidation are known, but for sulphation two have been found: DCNP and PCP. These exclusively inhibit sulphation at low dose (although one should always check their effect on glucuronidation).
When harmol is infused at steady state in the rat, the intravenous injection of DCNP causes an immediate inhibition of sulphation (Fig. 3) . In the perfused rat liver this inhibition was reversible (Koster et al., 1982a) , its long duration of action in vivo being due to a very long t of DCNP. Baranczyk-Kuzma et al. (1981) and Duffef & Jakoby (1981) have shown that the inhibition by DCNP and PCP is competitive towards the acceptor substrate.
Interestingly, the blood concentration of unconjugated harmol was not increased when DCNP was administered during a harmol infusion; this suggests that inhibition of sulphation probably leads to a higher intracellular concentration of harmol, which subsequently results in a higher glucuronidation rate that compensates completely for the loss of sulphation.
Conclusions
In vivo, the role of enzyme kinetic parameters of the transferases in many cases is obscured by other events affecting the overall activity of conjugation. When sulphation and glucuronidation compete for the same substrate it is important that a proper awareness of the pharmacokinetics of the situation is shown, in order to avoid inaccurate interpretation of the data obtained from, especially, in vivo metabolic experiments. This work was supported by a NATO grant (RG 35.82 ) and a grant from The Royal Society (London) to J. R. D.
